The efficacy of intravesical BCG in the treatment of patients with high risk superficial bladder cancer
- 1 November 1991
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 23 (6) , 559-567
- https://doi.org/10.1007/bf02549846
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Recurrence of Superficial Bladder Carcinoma after Intravesical Instillation of Mitomycin‐Comparison of Exposure TimesBritish Journal of Urology, 1989
- Should pT1 Transitional Cell Cancers of the Bladder still be Classified as Superficial?British Journal of Urology, 1988
- Prognostic Indices in Transitional Cell Carcinoma of the BladderBritish Journal of Urology, 1988
- BCG in management of superficial bladder cancerUrology, 1987
- Instillation of Mitomycin C and Doxorubicin in the Prevention of Recurrent Superficial (Ta—T1) Bladder CancerBritish Journal of Urology, 1987
- Recurrence, Progression and Survival in Bladder CancerScandinavian Journal of Urology and Nephrology, 1987
- Superficial Bladder Cancer: Intravesical Chemotherapy and Tumour Progression to Muscle Invasion or MetastasesBritish Journal of Urology, 1986
- UROTHELIAL DYSPLASIA CONCOMITANT WITH BLADDER TUMOURS AS A DETERMINANT FACTOR FOR FUTURE NEW OCCURRENCESThe Lancet, 1983
- Ta and T1 Bladder Cancer: Location, Recurrence and Progression†British Journal of Urology, 1982
- The Correlation of TI Bladder Tumour History with Prognosis and Follow-up RequirementsBritish Journal of Urology, 1981